PPR-054 - Community pharmacy-based testing and treatment for chlamydia trachomatis and neisseria gonorrhoeae (Swab-Rx Study)

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: PPR-054
• By: RAMSEY, Tasha (Dalhousie University, Canada)
• Co-author(s): Dr Tasha Ramsey (Dalhousie University, Halifax, Canada / Nova Scotia Health Authority, Halifax, Canada)
  Ms. MacKenzie d’Entremont-Harris (Nova Scotia Health Authority, Halifax, Canada)
  Mr Shea McInnis (Nova Scotia Health Authority, Halifax, Canada)
  Mr. Connor Booker (Nova Scotia Health Authority, Halifax, Canada)
  Dr. Todd Hatchette (Dalhousie University, Halifax, Canada / Nova Scotia Health Authority, Halifax, Canada)
  Dr. Andrea Bishop (Nova Scotia College of Pharmacists, Halifax, Canada)
  Dr. Kyle Wilby (Dalhousie University, Halifax, Canada)
  
• Abstract:

  Background information: Sexually transmitted infections are on the rise globally with an estimated 129 million chlamydia and 82 million gonorrhoea new infections in 2020. Chlamydia trachomatis and Neisseria gonorrhoeae are the first and second most reported bacterial sexually transmitted infections in Canada. Accessible, efficient, and convenient..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login